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Abstract 
Background: Despite the use of maintenance medication, recurrence rates in bipolar affective disorder (BPAD) are 
high. To date, there are no clinical trials that have investigated the use of psychological interventions in bipolar disor-
der in Pakistan.
Aim: The purpose of the study was to assess the feasibility and acceptability of a culturally adapted bipolar psychoe-
ducation programme (CaPE) in Pakistan.
Methods: Thirty-four euthymic bipolar I and II outpatients were randomized to either 12 weekly sessions of indi-
vidual psychoeducation plus Treatment As Usual (Intervention) or Treatment As Usual (TAU) (Control). Outcomes 
were assessed using the Young Mania Rating Scale (YMRS), Beck Depression Inventory (BDI), EuroQoL (EQ-5D), Bipolar 
Knowledge and Attitudes and Questionnaire (BKAQ), and a self-reported measure of medication adherence (Morisky 
Medication Adherence Scale-4 items, MMAS-4). Effect sizes were derived from baseline adjusted standardized regres-
sion coefficients.
Results: Retention in the study was good, 80% of patients in the TAU follow-up assessment and 100% of patients 
in the CaPE group attended all 12 sessions. Patient satisfaction was higher in the CaPE group relative to control 
(ES = 1.41). Further, there were large effect sizes shown for CaPE versus TAU for medication adherence (MMAS-4: 
ES = 0.81), knowledge and attitudes towards bipolar (BKAQ: ES = 0.68), mania (YMRS: ES = 1.18), depression (BDI: 
ES = 1.17) and quality of life measures (EQ-5D: ES ⇒ 0.88).
Conclusions: Culturally adapted psychoeducation intervention is acceptable and feasible, and can be effective in 
improving mood symptoms and knowledge and attitudes to BPAD when compared with TAU. Larger scale studies are 
needed to confirm our findings.
Trial registration. Clinicaltrials.gov identifier NCT02210390
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Background
Bipolar disorder (BD) is a significant cause of disability 
across the world (Wittchen et al. 2011; Vos et al. 2012). 
It is a common disorder, and for most sufferers, is highly 
recurrent and associated with significant psychosocial 
impairment as well as a high rate of completed suicide 
(Fajutrao et al. 2009) .
Long-term, or maintenance, pharmacological treat-
ment with mood stabilizers, such as lithium, and spe-
cific antipsychotic drugs play an important role in the 
treatment of bipolar disorder. Despite the use of main-
tenance drug treatment, recurrence rates of bipolar 
disorder are high; a recent meta-analysis of long-term 
naturalistic studies reported a mean risk of at least one 
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new syndromal BD episode of 55.2% (26.3%/year) with 
clinically determined treatments (Vázquez et  al. 2015). 
This may partly reflect medication non-adherence. Two 
large Veterans Administration (VA) studies reported that 
approximately 50% of bipolar patients miss ≥20% of pre-
scribed maintenance medication (Sajatovic et  al. 2006, 
2007). The limited efficacy of pharmacotherapy in bipo-
lar disorder (Thase and Sachs 2000; Tohen et  al. 2002) 
has increased the interest in  the potential of adjunctive 
psychosocial interventions to enhance mood stability of 
patients in the long term. Studies suggest that the addi-
tion of non-pharmacological strategies helps not only 
in adherence to pharmacological treatment but can also 
improve patient’s psychological functioning in relapse 
prevention (Scott et  al. 2007; Salcedo et  al. 2016). A 
recent meta-analysis suggests that pharmacotherapy 
plus psychological intervention may significantly reduce 
recurrence rates and hospital admissions (Oud et  al. 
2016).
A variety of psychological interventions exist for bipo-
lar disorder, including psychoeducation, CBT (Cogni-
tive Behaviour Therapy), family focussed therapy and 
interpersonal and social rhythm therapy. The distinction 
between these different therapies is far from precise, and 
they share some common features, including provision 
of psychoeducation. Bearing this in mind, several guide-
lines recommend psychoeducation (PE) as the first-line 
choice of psychological intervention in bipolar disorder 
(Goodwin et al. 2016; Yatham et al. 2013). PE is a psycho-
social approach that views bipolar disorder as a medical 
condition that would most greatly be benefited by edu-
cation about the condition which empowers patients to 
play a larger role in their treatment. PE for bipolar dis-
order is aimed at improving medication adherence and 
also includes strategies to enhance awareness of triggers 
and associated problem solving strategies. PE encourages 
patients to be active participants in their own treatment 
and is often delivered in a group format (Stafford and 
Colom 2013). Structured PE programmes usually include 
the provision of information about the recurrence rate of 
the illness, medication and its adverse effects, triggering 
factors, the importance of adherence to treatment, how 
to manage symptoms, stress management, the risk of sui-
cide, relevance of pregnancy, stigmatization, recognition 
of early recurrence symptoms, the avoidance of use of 
alcohol and other substances and the importance of lead-
ing a well-structured life (Colom et al. 2003). PE can be 
delivered in a group setting or on an individual basis and 
its proponents argue that it is a relatively straightforward 
and cost effective intervention (Scott et al. 2009; Yatham 
et al. 2013; Bond and Anderson 2015).
There are only a few studies investigating psychoedu-
cation for bipolar disorder from low- and middle-income 
studies and these report conflicting findings (Javadpour 
et al. 2013; Cardoso Tde et al. 2014; Gumus et al. 2015).
Objectives
The primary objective of this study was to pilot a 12-week 
individual culturally-adapted psychoeducational inter-
vention (CaPE) to determine its’ feasibility in terms of 
recruitment, retention, adherence to the intervention 
and patient satisfaction with overall care. Secondary 
objectives included determining the efficacy of the CaPE 
intervention on improvement of knowledge and attitudes 
towards bipolar disorder, adherence to medication, and 
improvement of mood symptoms and quality of life.
Methods
Research design
The study was conducted between June 2012 and May 
2015, and participants were recruited from outpatient 
psychiatric clinics of teaching hospitals in Karachi, Paki-
stan. A total of 34 participants were recruited to the pilot 
study and randomly allocated into two arms.; Interven-
tion (individual Culturally adapted Psychoeducation, 
CaPE) and Treatment-As-Usual (TAU). Previous studies 
have recommended that sample sizes between 24 and 
50 are sufficient for the purposes of a pilot trial (Julious 
2005; Sim and Lewis 2012).
An off-site statistician carried out randomization using 
a web software (http://www.randomisation.com). The 
participants were followed up by a research assistant 
who completed baseline assessments and follow-up at 
12 weeks (end of intervention).
Inclusion and exclusion criteria
The inclusion criteria were: Diagnosis of DSM IV bipo-
lar affective disorder, currently euthymic (BDI  <  12 and 
YMRS  <  8), age 18–65  years, participants engaged with 
the mental health services for preceding 6 months, able 
to give written informed consent, resident of the trial 
catchment area, and ability to speak Urdu/Punjabi/
English.
The exclusion criteria were as follows: Severe cogni-
tive impairment, currently experiencing relapse (mania, 
hypomania, mixed or depressive), being actively suicidal, 
the presence of any comorbid psychiatric illness such as 
substance misuse or alcohol dependence, according to 
DSM IV criteria.
Recruitment of participants
In the first instance, the research clinician approached 
the clinical teams to inform them about the research 
study and the inclusion and exclusion criteria. The diag-
nosis of bipolar disorder was established by the patients’ 
regular outpatient psychiatrist based on DSM IV criteria. 
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If patients met the entry criteria and were clinically sta-
ble and the clinical team agreed that the patient could be 
a possible participant, they introduced the study to the 
patient. With the patient’s agreement, the research clini-
cian then approached the patient to explain the research 
study verbally and to provide them with the participant 
information sheet. Those patients who were confirmed 
to be eligible for the study and agreed to take part pro-
vided written informed consent and were recruited to the 
study.
Interventions
Psychoeducation
This intervention consisted of 12 psychoeducation ses-
sions, one session per week, that were administered on 
an individual patient basis, added to treatment as usual. 
Each session lasted for approximately 1  h, beginning 
with a 20–30  min presentation on the topic of the day, 
followed by a related exercise (e.g., drawing a life chart 
or compiling a list of potential triggers for relapse). Con-
tent was a reduced and modified version of the Barcelona 
Psychoeducation Program for bipolar disorders (Colom 
et  al. 2003). The content of the sessions is summarized 
in Table 1. All sessions were provided by a Masters level 
clinical psychologist. The same psychologist provided 
each of the 12 sessions to ensure continuity. This psychol-
ogist received regular weekly supervision from authors 
NH and FN to ensure fidelity to the manual. Therapy ses-
sions were recorded and tapes were randomly selected by 
the supervisor. Permission was obtained to translate and 
adapt the Barcelona programme for the purposes of the 
study. Baseline and follow-up ratings were conducted by 
blind raters.
Cultural factors played a role in the decision to use 
individual psychoeducation in this study, since mental 
illness remains a source of stigma, particularly within 
Pakistani society. There is low awareness about the causes 
of mental illness in Pakistan (Waqas et al. 2014) which, in 
combination with low literacy rates, poor socioeconomic 
conditions and complex belief systems regarding black 
magic, possession and Jinn (demons) leads to public 
stigma. We opted to use individual psychoeducation due 
to a concern that patients may not be willing to discuss 
their personal difficulties in a group setting which in turn 
could lead to a high dropout rate.
Cultural adaptation of the intervention
Our group has culturally adapted interventions for 
depression using mixed methods, in Pakistan and the UK 
(Gater et al. 2010; Husain et al. 2014; Masood et al. 2015; 
Naeem et  al. 2015a, b, c). The framework used consid-
ered three areas: assessment and engagement, awareness 
of cultural factors and adjustments in implementation 
(Naeem et  al. 2015a, b, c). Most cultural adaptations of 
psychological treatments tend to be for implementation 
of the treatments rather than their content (Chowdhary 
et al. 2014), and we used the same principle for the CaPE 
intervention. For the purposes of the CaPE intervention, 
we used culturally acceptable idioms when explaining the 
concept, causes and symptoms of bipolar disorder (ses-
sions 1–3) while taking into account participants’ lay per-
ceptions on causes and treatment of mental illness. We 
also used local folk stories and images (e.g., to explain 
the concept of multiple perspectives) as well as exam-
ples from religious teachings. We incorporated simple 
strategies to improve engagement, which have worked in 
the past. These included speaking in the native language 
(Urdu) using culturally appropriate terms instead of jar-
gon, and establishing a good rapport and a trusting rela-
tionship during the session. If the patient agreed, we also 
involved the main carer and families in the session, par-
ticularly for sessions 6, 7, and 8 (risks of treatment dis-
continuation and detection and management of relapse).
Treatment‑as‑usual
This group of patients received routine treatment, which 
in Pakistan means attending the outpatient clinic and 
taking prescribed medication.
Outcome measures
The primary outcome of the study was the feasibility 
of the intervention in terms of recruitment and reten-
tion rates and patient satisfaction with overall care. 
Acceptance of the intervention was assessed using data 
on attendance and drop out. Patient satisfaction was 
assessed using a Visual Analogue Scale (VAS).
Secondary outcome measures included knowledge and 
attitudes towards bipolar disorder measured by using a 
Table 1 Sessions of  the Culturally adapted Psychoeduca-
tion (CaPE) intervention
Session 1: Concept and causes
Session 2: Symptoms: Mania, Hypomania, Depression and mixed condi-
tions
Session 3: Evolution and prognosis, psychoactive substance misuse
Session 4: Treatment with medication (Mood stabilizers, antipsychotics, 
antidepressants)
Session 5: Alternative therapies
Session 6: Risks associated with interruption of treatment
Session 7: Learning to detect early symptoms of relapse
Sesison 8: What to do when a relapse is detected?
Sesion 9: Regularity of habits
Session 10: Stress-control
Session 11: Prolem-solving strategies
Session 12: Final session
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questionnaire developed for use in primary care (BKAQ, 
see Additional file 1). Morisky 4-item self-reported meas-
ure of medication adherence (MMAS-4) (Morisky et  al. 
1986) was used to measure adherence to prescribed med-
ication. Severity of mood symptoms was measured using 
the Young Mania Rating Scale (YMRS) (Young et  al. 
1978) (score of ≥20 indicating manic relapse), or Beck’s 
Depression Inventory (BDI) (Beck et  al. 1961) (score of 
≥14 indicating depressive relapse). Health-related qual-
ity of life was also measured using EuroQoL (EQ-5D) 
(Brooks and EuroQol Group 1996). All assessment scales 
were translated for use in Urdu and have previously been 
used in Pakistan (Farooq et al. 2010, Hashmi et al. 2007; 
Husain et  al. 2014). The BDI has been assessed as valid 
for use in Pakistan however there is no evidence in the 
current literature regarding the cross-cultural validity of 
the YMRS (Ahmer et al. 2007; Husain et al. 2014; Khan 
et al. 2015).
All outcomes were measured at baseline and at week 12 
(end of CaPE intervention).
Statistical analysis
The aim of the analysis was to describe the feasibility 
and acceptability of the trial and CaPE intervention and 
estimate effect sizes for group differences in attitude, 
adherence, clinical and quality of life outcomes. For the 
EQ-5D two aspects of the EQ-5D were used, the 5 rat-
ing dimensions were combined into a weighted score 
with 1 indicating perfect health and 0 death (Brooks 
and EuroQol Group 1996). For the main analysis the 
UK weighting scheme was used with weighting for Thai-
land considered as a sensitivity analysis. Effect sizes 
were derived from standardized regression coefficients 
in which treatment group differences, adjusted for out-
comes scores at baseline, were divided by the standard 
deviation of the outcomes. Following Cohen’s guide-
lines, effect sizes were treated as small (ES = 0.2), mod-
erate (ES = 0.5) or large (ES = 0.8). As a pilot study, the 
sample size did not give sufficient power to reject null 
hypotheses; however, we derived inferential statistics 
on the intention to treat principle. Continuous outcome 
scores were analysed using ANCOVA models in which 
the mean group difference was adjusted for baseline 
outcome scores. As sample size was small and regres-
sion residuals not normally distributed we used boot-
strap resampling (2000 iterations) to derive standard 
errors and bias corrected accelerated confidence inter-
vals. Binary outcomes were analysed using Chi square 
or Fisher’s exact test if expected values were small. All 
statistical tests were two-sided and confidence interval 
level set at 95%. STATA 14.1 (StataCorp) was used to 
analyse the data.
Results
There was little difference in socio-demographic vari-
ables between the two randomized groups, and this dif-
ference was not found to be statistically significant. 61.1% 
of participants in the CaPE group and 62.5% in the TAU 
group were male. There were proportionally more single 
persons in the TAU group (69%) than in the CaPE (39%) 
group. There was more unemployment in TAU (63%) 
than CaPE (50%). In the CaPE group, 22.2% or partici-
pants had over three previous hospital admissions com-
pared to 37.5% of the TAU group (Table 2).
Figure  1 summarizes participant flow through the 
study. 90 people were identified as suitable for recruit-
ment. Of the 90 patients approached, 56 met the inclu-
sion criteria. Of these 56 patients, 46 were recruited into 
the trial with 12 not willing to participate. 34 patients 
were subsequently randomized.
Of the 34 patients randomized, all were taking some 
form of prescribed psychotropic medication. 22 par-
ticipants were taking a mood stabilizer (i.e., Lithium, 
Sodium Valproate, Lamotrigine) and 22 participants were 
taking an antipsychotic medication. 9 participants within 
the sample were taking an antidepressant and 7 were tak-
ing a benzodiazepine.
Retention within the trial was very good. 27 of the ran-
domized participants completed the study. Of the 16 ran-
domized to the TAU group, 5 were lost to follow up. Only 
2 participants dropped out of the 18 randomized to the 
CaPE group. These participants were also lost to follow 
up. Acceptance of the CaPE intervention was good with 
89% of participants attending all 12 sessions. There was 
no significant difference between group patient satisfac-
tion scores at baseline but satisfaction was much higher 
for patients in the CaPE intervention than TAU (ES: 1.41, 
p < 0.001) after 12 weeks. It is worth noting that the dif-
ference in patient satisfaction at 3  months, between 
those participants in the CaPE intervention and those 
receiving TAU, is partly caused by a decrease in the sat-
isfaction scores for those in the TAU group (Mean differ-
ence = −3.7, SD = 4.3).
For psychoeducation outcomes and clinical outcomes, 
Table 3 presents the effect sizes and results of the statisti-
cal modelling. Knowledge and attitudes towards bipolar 
(BKAQ) showed a moderate to large effect size (stand-
ardized ES = 0.68; non-significant) with scores higher in 
CaPE than TAU. Medication adherence also improved in 
the CaPE group relative to TAU (ES = −0.81; p = 0.018). 
For clinical outcomes, patients in the CaPE interven-
tion showed large improvements in manic and depres-
sive symptoms in comparison to TAU, as measured 
by the YMRS (ES  =  −1.18, p  <  0.001) and BDI scale 
(ES  =  −1.17, p  <  0.001). Quality of life measures also 
showed large effect sizes for CaPE versus TAU (EQ-5D 
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Index: ES  =  0.88, p  =  0.014; EQ-5D VAS; ES  =  1.14, 
p < 0.001). For the EQ-5D index score, using weights for 
Thailand rather than the UK gave a very similar result, 
(ES: 0.88, p = 0.011) indicating that the treatment group 
difference is robust.
Discussion
The results of this exploratory trial show that culturally 
adapted psychoeducation was an acceptable and feasible 
intervention in a low-resource setting. Furthermore, our 
study indicated substantial effect sizes for improvements 
in measures of knowledge and attitudes towards bipolar 
disorder and medication adherence, following 12 sessions 
of psychoeducation (CaPE) when compared to the TAU 
group. The CaPE group also reported large improvements 
in clinical outcomes YMRS and BDI scores, compared to 
treatment as usual as well as EQ-5D quality of life scores.
Psychological interventions in low- and middle-income 
countries, including Pakistan, are not readily available. 
We are not aware of any studies of psychological inter-
ventions for bipolar disorder in Pakistan or other parts of 
the Indian Subcontinent. However, recent studies from 
low-income countries have reported CBT to be an effec-
tive treatment for other psychiatric problems such as 
major depressive disorder, psychotic disorder, and self-
harm (Chatterjee et al. 2009; Husain et al. 2014; Naeem 
et  al. 2015a, b). Social and cultural factors influence 
perception of symptoms of mental illness and hence, 
engagement with services (Bhikha et  al. 2012). Psycho-
logical interventions need to be tailored according to 
Consent withdrawn (n = 
12)
Number of patients 
approached (n= 90)
Number of patients 
who met inclusion 
criteria (n= 56)
Number of patients 
recruited (n = 46)
Number of patients 
randomized (n= 34) 
CaPE group 
(n=18) 
TAU group 
(n=16) 
3rd Month 
Assessment 
(n=11) 
3rd Month 
Assessment 
(n=16) 
Drop-outs (n= 
5)
Drop-outs (n = 
2)
Excluded (n = 34)
Did not meet inclusion 
criteria:
Participant declined (n= 
24) 
Too unwell (n= 6) 
Age >65 (n = 4) 
Fig. 1 CONSORT diagram showing trial progress
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socio-cultural needs of patients. Evidence suggests that 
cultural adaptation of psychological intervention is cru-
cial (Naeem et  al. 2009). Previous systematic reviews of 
the efficacy of culturally adapted mental health interven-
tions have found a moderately strong benefit of culturally 
adapted interventions (Griner and Smith 2006; Chowd-
hary et al. 2014). Studies have reported that interventions 
targeted to a specific cultural group were four times more 
effective than interventions provided to groups consist-
ing of participants from a variety of cultural backgrounds 
(Griner and Smith 2006). Furthermore, interventions 
conducted in the participants’ native language (if other 
than English) were twice as effective as interventions 
conducted in English (Griner and Smith 2006).
To the best of our knowledge, this is the first trial in 
Pakistan to investigate the feasibility and efficacy of 
individual culturally adapted psychoeducation in the 
management of bipolar disorder. Previous studies in 
high-income countries indicate that individual PE can 
be effective in improving clinical outcomes (Bond and 
Anderson 2015; Salcedo et  al. 2016). Similarly, feasibil-
ity studies of PE interventions for bipolar disorder have 
indicated that they are feasible and acceptable treatment 
options in high-income countries (Fiorillo et  al. 2016; 
Poole et al. 2015). Our results are comparable to findings 
from studies in other low- and middle-income settings. A 
study in Iran showed that following individual psychoed-
ucation for bipolar disorder given in 8 sessions, there was 
a decrease in the number of relapses, in the rates of hos-
pitalization and improvement in medication compliance 
when compared to the control groups (Javadpour et  al. 
2013). However, a study of young adults (aged 18-29) with 
bipolar disorder, receiving 8 sessions of individual psych-
oeducation added to treatment as usual in Brazil, did not 
find any significant difference in depressive and manic 
symptom improvement nor in quality of life measures 
between intervention and control groups (Cardoso Tde 
et al. 2014). Another study conducted in Turkey reported 
that four-session individual psychoeducation did not sig-
nificantly decrease the number of relapses although the 
intervention group had a lower number of relapses, lower 
number of multiple mood episodes, and a lower hospital-
ization rate (Gumus et al. 2015). These findings indicate 
that the number of sessions of psychoeducation may be 
an important factor in determining efficacy.
A fully powered and longer clinical trial will address 
certain limitations. The first of these is that the study 
was carried out in a single centre; thus our findings may 
not be generalizable to the rest of Pakistan or indeed the 
rest of the South Asian population. Second, as this was 
a pilot trial, our sample size was small and not powered 
to detect efficacy of the intervention. It is important to 
interpret the effect sizes relating to clinical outcomes 
cautiously since most outcome measures were self-report 
scales and may be at risk of recall bias, social desirabil-
ity bias and errors in self-observation. Moreover, using 
TAU as a control is likely to inflate the effect sizes for the 
intervention. Future studies should consider using atten-
tion placebo controls such as unstructured social support 
or befriending to minimize the risk of bias. In order to 
determine reliable data regarding the clinical efficacy of 
CaPE, future trials should also match groups for poten-
tial confounding factors such as concomitant pharmaco-
logical treatment, duration of illness, and type of disorder 
(i.e., type I or type II). Sub-types of bipolar disorder differ 
in terms of illness severity, clinical and social outcomes, 
response to treatments, and personal disability, and these 
differences may have had an impact on our findings. 
Furthermore, as we excluded patients with a psychiatric 
co-morbidity, our findings are not generalizable to those 
bipolar patients with comorbidities. Finally, the period 
for evaluating the effectiveness of CaPE in the present 
study was only 3 months after randomization, and there-
fore, we are unable to comment on the long-term efficacy 
of the intervention.
Conclusions
The intervention used in our study was empirically based 
and culturally relevant. The results of the study indicate 
that CaPE was acceptable and feasible with very low drop 
out rate. We used blind raters to prevent rater bias in the 
assessment of YMRS scores. The results are quite prom-
ising and strongly indicate that a larger scale randomized 
Table 2 Demographic characteristics of participants
TAU (N = 16) CaPE (N = 18) p value
Age: median (IQR) 34.5 (27.5–43.5) 34.5 (28–40) 0.89
Gender
 Male: n (%) 10 (62.5) 11 (61.1) 1.00
Marital status
 Single: n (%) 11 (68.8) 7 (38.9) 0.18
 Married: n (%) 6 (31.3) 10 (55.6)
 Divorced: n (%) 0 (0) 0 (0)
Socio-economic status
 Low: n (%) 4 (25.0) 2 (11.1) 0.50
 Lower-middle: n (%) 2 (12.5) 4 (22.2)
 Middle: n (%) 10 (62.5) 12 (66.7)
Employment
 Unemployed: n (%) 10 (62.5) 9 (50.0) 0.51
 Employed: n (%) 6 (37.5) 9 (50.0)
Number of prior inpatient psychiatric admisisons
 Nil: n (%) 10 (62.5) 9 (50.0) 0.07
 Up to two: n (%) 0 (0) 5 (27.8)
 Three or more: n (%) 6 (37.5) 4 (22.2)
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controlled trial of a culturally adapted psychoeducation 
intervention in bipolar disorder is warranted. In addition, 
the trial shows that such an intervention could potentially 
improve clinical outcomes and quality of life in Pakistani 
patients suffering from bipolar disorder. A study with a 
larger sample size and longer period of follow-up will be 
useful to determine the clinical and cost effectiveness of 
CaPE and will help with the planning of efficient and cul-
turally appropriate interventions in Pakistan that could 
serve as a model for other low-income countries.
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